Shenqi fuzheng, an injection concocted from chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: A systematic review

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Dong, Ju ^a   Su, Shi Yue ^b   Wang, Min Yan ^a   Zhan, Zhen ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Chuzhou People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CHINESE DRUG; CISPLATIN; DOCETAXEL; GEMCITABINE; HEMOGLOBIN; NAVELBINE; PACLITAXEL; SHENQI FUZHENG INJECTION; UNCLASSIFIED DRUG; HERBACEOUS AGENT; PLATINUM DERIVATIVE; SHENQI FUZHENG;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DRUG SAFETY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; LUNG NON SMALL CELL CANCER; MEDICINAL PLANT; META ANALYSIS; NAUSEA AND VOMITING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SHENQI FUZHENG; SIDE EFFECT; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; TREATMENT RESPONSE; EVIDENCE BASED MEDICINE; LUNG TUMOR; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DRUGS, CHINESE HERBAL; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; PLATINUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77958053189     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-137     Document Type: Article

References (52)

1. Non-small cell lung cancer: epidemiology risk factors, treatment, and survivorship. JR Molina P Yang SD Cassivi SE Schild AA Adjei, Mayo Clin Proc 2008 83 5 584 594 10.4065/83.5.584 18452692
2. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. R Suresh P Chandra, The Oncologist 2008 3 suppl 1 5 12
3. Should chemotherapy (Cx) for advanced non-small cell lung cancer (NSCLC) be platinum-based? a literature-based meta-analysis of randomized trials. F Barlesi JL Pujol J-P Daures, J Clin Oncol 2005 23 16s 673s
4. Platinum-based versus non platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature. G D'Addario M Pintilie NB Leighl R Fied T Gerny FA Shepherd, J Clin Oncol 2005 23 13 2926 2936 10.1200/JCO.2005.03.045 15728229
5. Astragalus-based chinese herbs and platinum-based chemotherapy for advanced non small cell lung cancer: meta-Analysis of randomized trials. M McCulloch C See XJ Shu M Broffman A Kramer WY Fan J Gao W Lieb K Shieh JM Colford Jr, J Clin Oncol 2006 224 3 419 430 10.1200/JCO.2005.03.6392 (Pubitemid 46655594)
6. Meta-analysis of Ai Di injection combined with NP chemotherapy in the treatment of late stage non-small cell lung cancer. BC Wu L Xu M Chen, Zhejiang Journal of Integrated Traditional Chinese and Western Medicine 2009 19 7 446 447
7. Clinical application and curative effect evaluation of Shenqi fuzheng injection. LR Yang XY Xu, Heilongjiang Journal of Traditional Chinese Medicine 2004 4 46 48
8. Clinical application and pharmacology function of Shenqi fuzheng injection. Y Lu YX Lu, Li Shi Zhen Medicine and material medica research 2006 17 10 2083 2085
9. Practical road of "the numeral turn Chinese herbal medicine" for Shenqi fuzheng injection. L Pan, Journal of China Prescription Drug 2009 1 82 37 39
10. Dictate history: A national new medicine that come from experiential prescription. ZH Zhong, Journal of China Prescription Drug 2009 1 82 33 36
11. J Higgins S Green (eds), Cochrane handbook for systematic reviews of interventions 4.2.6. In the Cochrane library Wiley: Chichester 2006 301 4 (updated September 2006)
12. WHO, WHO Handbook for Reporting Results of Cancer Treatment Geneva, Switzerland, World Health Organization 1979
13. Evaluation of patients with advanced cancer using the Karnofsky performance status. JW Yates B Chalmer FP McKegney, Cancer 1980 45 2220 2224 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR28204508353.0.CO;2-Q 7370963
14. Meta-analysis in clinical trials. R DerSimonian N Laird, Control Clin Trials 1986 7 177 188 10.1016/0197-2456(86)90046-2 3802833
15. AJ Sutton KR Abrams DR Jones TA Sheldon F Song, Methods for Meta-Analysis in Medical Research Chichester, United Kingdom, John Wiley & Sons 2000
16. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: A meta-analysis. C Delbaldo S Michiels N Syz, JAMA 2004 292 470 484 10.1001/jama.292.4.470 15280345
17. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. M Oremus C Wolfson A Perrault L Demers F Momoli Y Moride, Dement Geriatr Cogn Disord 2001 12 232 236 10.1159/000051263 11244218
18. An introduction to sensitivity analysis. L Breierova M Choudhari, MIT Pr 1996 41 107
19. Systematic reviews in health care: Meta-analysis in context. M Egger SG Davey DG Altman, London: BMJ books 2001
20. The influence of Shenqi fuzheng injection combined with chemotherapy on the survival quality of late-stage non-small cell lung cancer. XL Hao XJ Lv, Chinese Journal of Practical oncology 2008 22 5 458 459
21. Clinical observation of Shenqi fuzheng injection combined with NP chemotherapy in the treatment of late stage non-small cell lung cancer. K Wang JX Tan Y Nong, Modern Journal of Integrated Traditional Chinese and Western Medicine 2007 16 26 3797 3798
22. Shenqi fuzheng injection combined with chemotherapy for the late stage non-small cell lung cancer 36 cases. GY Kang B Li, Chinese Journal of Integrative Medicine 2006 26 6 565 566
23. Clinical observation of Shenqi fuzheng injection combined with NP chemotherapy for the elder late-stage non-small cell lung cancer. ZM Gong Y Wang CY Yu HY Chen, Information on Traditional Chinese Medicine 2008 15 9 64 65
24. Clinical observation and nursing of Shenqi fuzheng injection combined with NP chemotherapy for the elder late-stage non-small cell lung cancer. XY Wang ZQ Hang H Li CB Cai, Journal of Chinese Lung Cancer 2007 10 3 234 236
25. Clinical observation of Shenqi fuzheng injection combined with vinorelbine plus carboplatinum for the late stage non-small cell lung cancer. YZ Wang ZX Yang SH Liao X Shen, Journal of Chinese clinical intern Medicine 2007 24 3 206 207
26. Clinical observation of Shenqi fuzheng injection combined with chemotherapy for the late stage lung cancer. TW Li L Xiang FY Tong CH Zhang, Journal of Progress in Modern Biomedicine 2009 9 10 1917 1919
27. Clinical observation of Shenqi fuzheng injection combined with NP chemotherapy for the late stage non-small cell lung cancer. Y Li SX Chen RW Huang, Journal of Chinese Modern Medicine 2007 9 3 40 41
28. Clinical observation of Shenqi fuzheng injection combined with chemotherapy for the late stage non-small cell lung cancer. J Lv, China Medical Herald 2008 5 36 73 74
29. The short-term curative effect of Shenqi fuzheng injection combined with NP chemotherapy for the elder late stage non-small cell lung cancer. ZY Zhao DL Wu M Chen H Jiang GJ Yan, Journal of Chinese modern oncology 2007 15 1 42 43
30. Shenqi fuzheng injection combined with chemotherapy for the non-small cell lung cancer. L Geng, Journal of Medical Forum 2004 25 17 29 30
31. Shenqi fuzheng injection combined with chemotherapy for the middle and late stage non-small cell lung cancer. QZ Yu, Chinese Journal of Integrative Medicine 2007 27 5 473 474
32. Clinical observation of Shenqi fuzheng injection combined with chemotherapy for the elder non-small cell lung cancer. CL Liu WP Chen SZ Cui GY Den LP Liu LH Tan XC Su BC Yan JX Kong, Chinese Journal of Integrative Medicine 2004 24 10 901 903
33. The curative effect observation of Shenqi fuzheng injection combined with chemotherapy for the late stage lung cancer. FH Liu GQ Liao HM Wang, Journal of Third Military Medical University 2007 29 3 259 260
34. Clinical observation of Shenqi fuzheng injection assisted with chemotherapy for the non-small cell lung cancer. YK Pan M Huang M Qu, Journal of Chinese Clinical Medical 2008 3 4 43 45
35. Shenqi fuzheng injection combined with NP chemotherapy in treating elder late stage non-small cell lung cancer patients 42 cases. JH Zhen YF Chen, JiangXi Journal of Traditional Chinese Medicine 2009 40 6 58 59
36. Clinical observation of Shenqi fuzheng injection combined with NP chemotherapy in treating elder late stage non-small cell lung cancer. SR Miao WH Yang CH Geng, Chinese Journal of Practical Medicine 2010 5 11 16 17
37. The clinical study on reducing toxicity effect of Shenqi fuzheng injection combined with NP chemotherapy for non-small cell lung cancer. YQ Li X Zhou T Zhang HJ Chen, Chinese Journal of New Drugs 2010 19 2 23 126
38. The curative effect observation of Shenqi fuzheng injection combined with NP chemotherapy for the late stage non-small cell lung cancer. D Geng JC Cui L Ma, Chinese Journal of Practical Medicine 2007 2 5 57 59
39. Clinical observation of Shenqi fuzheng injection combined with paclitaxel plus carboplatinum chemotherapy in treating patients with late stage non-small cell lung cancer. Y Zou YJ Bo PG Ruan, Chinese Journal of Practical oncology 2005 20 3 260 262
40. Clinical observation of Shenqi fuzheng injection combined with paclitaxel plus cisplatinum chemotherapy for late stage non-small cell lung. SZ Luo JH Long XY Yu, Journal of Chinese cancer research and clinic 2006 18 3 181 183
41. Clinical observation of middle and late stage non-small cell lung cancer treated with Shenqi fuzheng injection combined with paclitaxel plus carboplatinum. SW Luo YP Huang HL Shan YW Yang C Mo XE Wu, Chinese Journal of Clinical Oncology 2007 12 5 381 382
42. Clinical observation of middle and late stage non-small cell lung cancer treated with Shenqi fuzheng injection combined with paclitaxel plus carboplatinum. FL Zhang, Journal of Chinese Modern Oncology 2008 16 7 1165 1166
43. The curative effect observation of Shenqi fuzheng injection combined with paclitaxel plus carboplatinum for non-small cell lung cancer. YX Zhao CY Wang J Li F Wang, Journal of Chinese misdiagnose 2009 19 21 5129 5130
44. Clinical observation of Shenqi fuzheng injection assisted with chemotherapy for non-small cell lung cancer. F Yu K Li, Chinese Journal of Integrative Medicine 2007 21 2 166 167
45. Clinical observation of Shenqi fuzheng injection combined with gemcitabine plus cisplatinum for late stage Non-small Cell Lung Cancer. WJ He JQ Zhao, Journal of Chinese progress in oncology 2008 6 4 432 434
46. The curative effect observation of Shenqi fuzheng injection combined with chemotherapy for non-small cell lung cancer. K Liang SY Li, Journal of Chinese Tropical Medicine 2010 10 4 498 499
47. The clinical observation of Shenqi fuzheng injection combined with chemotherapy for non-small cell lung cancer. J Chen YJ Jia YY Sun YC Zhang, Chinese Medicine Emergency 2007 16 8 911 912
48. Shenqi fuzheng injection combined with chemotherapy in treating elder late stage non-small cell lung cancer patients 30 cases. L Wu B Jiang J Yang H Li, Chinese Journal of Integrative Medicine 2004 24 6 567 568
49. L Michael Borenstein V Hedges JPT Higgins HR, Introduction to Meta-Analysis Rothstein John Wiley & Sons, Ltd 2009
50. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. XQ Ma Q Shi JA Duan TT Dong KW Tsim, J Agric Food Chem 2002 50 4861 4866 10.1021/jf0202279 12166972
51. A study on the immune receptors for polysaccharides from the roots of astragalus membranaceus, a chinese medicinal herb. BM Shao W Xu H Dai P Tu Z Li XM Gao, Biochem Biophys Res Commun 2004 320 1103 1111 10.1016/j.bbrc.2004.06.065 15249203
52. The pharmacology efficacy and clinical application about dangshen. HJ Jiao, Chinese Journal of Clinical Medicine 2005 25 4 89 92